Intravenous immunoglobulin for presumed viral myocarditis in children and adults

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 5, 2015, Pages

  Robinson, Joan ^a   Hartling, Lisa ^a   Vandermeer, Ben ^a   Klassen, Terry P ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MANITOBA INSTITUTE OF CHILD HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; IMMUNOGLOBULIN; PLACEBO;

ADULT; AGE; CHILD; COMPARATIVE STUDY; DEATH; DISEASE DURATION; DISEASE SEVERITY; DRUG RESPONSE; EVENT FREE SURVIVAL; FOLLOW UP; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; INDIA; INFUSION RELATED REACTION; MYOCARDITIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SURVIVAL; SYSTEMATIC REVIEW; VIRUS ENCEPHALITIS; VIRUS MYOCARDITIS; ACUTE DISEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC); VIROLOGY; VIRUS DISEASES;

ACUTE DISEASE; ADULT; CHILD; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MYOCARDITIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VIRUS DISEASES;

EID: 84945330337     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD004370.pub3     Document Type: Review

References (48)

1. Bhatt GC, Sankar J, Kushwaha KP. Use of intravenous immunoglobulin compared with standard therapy is associated with improved clinical outcomes in children with acute encephalitis syndrome complicated by myocarditis. Pediatric Cardiology 2012;33(8):1370-6.
2. McNamara DM, Holubkov R, Starling RC, Dec GW, Loh E, Torre-Amione G, et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 2001;103(18):2254-9.
3. McNamara DM, Starling RC, Dec GW, Loh E, Torre-Amione G, Gass A, et al. Intervention in myocarditis and acute cardiomyopathy with immune globulin: Results from the randomized placebo controlled IMAC trial. Circulation 1999;100(18):104.
4. Alrabte SAH, Bezanti K. Role of intravenous immunoglobulin in the treatment of acute myocarditis. Cardiology in the Young 2013;Conference: 47th Annual Meeting of the Association for European Paediatric Cardiology, AEPC With Joint Sessions With the Japanese Society of Pediatric Cardiology and Cardiac Surgery and Asia-Pacific Pediatric Cardiac Society. London, United Kingdom. Conference Start: 20130522. Conference End: 20130525. Conference Publication:S96.
5. Anonymous Conventional therapy still the mainstay for myocarditis. Drugs & Therapy Perspectives 1997;9(5):5-7.
6. Anonymous High-dose intravenous immunoglobulin therapy in acute myocarditis. Respiration & Circulation 2002;50(7):697-703.
7. Bauer S, Gottesman G, Sirota L, Litmanovitz I, Ashkenazi S, Levi I. Severe Coxsackie virus B infection in preterm newborns treated with pleconaril. European Journal of Pediatrics 2002;161(9):491-3.
8. Bozkurt B, Alvarez RJ, Rosenblum WD, MacGowan GA, Feldman AM, Murali S, et al. Role of immune globulin in the treatment of postpartum cardiomyopathy. Journal of the American College of Cardiology 1998;31(2):330A-1A.
9. Bozkurt B, Villaneuva FS, Holubkov R, Tokarczyk T, Alvarez RJ, MacGowan GA, et al. Intravenous immune globulin in the therapy of peripartum cardiomyopathy. Journal of the American College of Cardiology 1999;34(1):177-80.
10. Drucker NA, Colan SD, Wessel DL, Belser AS, Takahashi M, Lewis AB, et al. Use of intravenous gamma-globulin in acute congestive cardiomyopathy. Circulation 1992;86(4):363.
11. Drucker NA, Colan SD, Lewis AB, Beiser AS, Wessel DL, Takahashi M, et al. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation 1994;89(1):252-7.
12. Felix SB, Staudt A, Dorffel WV, Stangl V, Merkel K, Pohl M, et al. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy - Three-month results from a randomized study. Journal of the American College of Cardiology 2000;35(6):1590-8.
13. Goland S, Czer LS, Siegel RJ, Tabak S, Jordan S, Luthringer D, et al. Intravenous immunoglobulin treatment for acute fulminant cardiomyopathy: series of six patients and review of literature. Canadian Journal of Cardiology 2008;24(7):571-4.
14. Gullestad L, Aass H, Fjeld JG, Wikeby L, Andreassen AK, Ihlen H, et al. Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure. Circulation 2001;103(2):220-5.
15. Haque A, Bhatti S, Siddiqui FJ. Intravenous immune globulin for severe acute myocarditis in children. Indian Pediatrics 2009;46(9):810-1.
16. Kishimoto C, Fujita M, Kinoshita M, Iwase T, Fujii B, Murashige A, et al. Immunoglobulin therapy for myocarditis and acute dilated cardiomyopathy. Circulation 1999;100(18):1405.
17. Klugman D, Berger JT, Sable CA, He J, Khandelwal SG, Slonim AD. Pediatric patients hospitalized with myocarditis: a multi-institutional analysis. Pediatric Cardiology 2009;31(2):222-8.
18. Levi D, Alejos J. An approach to the treatment of pediatric myocarditis. Pediatric Drugs 2002;4(10):637-47.
19. Maisch B, Outzen H, Roth D, Hiby A, Herzum M, Hengstenberg C, et al. Prognostic determinants in conventionally treated myocarditis and perimyocarditis - Focus on antimyolemmal antibodies. European Heart Journal 1991;12(Suppl D):81-7.
20. Maisch B, Hufnagel G, Schonian U, Hengstenberg C, for the ESETCID Investigators. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID). European Heart Journal 1995;16(Supplement O):173-5.
21. Maisch B, Pankuweit S, Funck R, Koelsch Hyperimmunoglobulin treatment is effective in CMV myocarditis - a controlled treatment trial (abstract P674). European Heart Journal 2004;25(Suppl 1):114.
22. Maisch B, Haake H, Schlotmann N, Pankuweit S. Intermediate dose of pentaglobin eradicates effectively inflammation in parvo B19 and adenovirus positive myocarditis [Abstract 1616]. Circulation 2007;116:II-338.
23. McNamara DM, Rosenblum WD, Janosko KM, Trost MK, Villaneuva FS, Demetris AJ, et al. Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. Circulation 1997;95(11):2476-8.
24. Muller J, Wallukat G, Brandes K, Spiegelsberger S, Bieda H, Kupetz W, et al. Successful therapy of idiopathic dilated cardiomyopathy by IgG immunoadsorption, results of a controlled study. Journal of the American College of Cardiology 1998;31(2):67A.
25. Shioji K, Kishimoto C, Sasyama S. Immunoglobulin therapy for acute myocarditis. Respiration & Circulation 2000;48(11):1133-9.
26. Staudt A, Schaper F, Stangl V, Plagemann A, Bohm M, Merkel K, et al. Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 2001;103(22):2681-6.
27. Takada H, Kishimoto C, Hiraoka Y. Therapy with gamma-globulin suppresses inflammatory lesions in coxsackievirus-B3 myocarditis. Circulation 1993;88(4):600.
28. Takada H, Kishimoto C, Hiraoka Y. Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model - antiviral and antiinflammatory effects. Circulation 1995;92(6):1604-11.
29. Hufnagel G, Pankuweit S, Richter A, Schonian U, Maisch B, for the ESETCID Investigators. The European study of epidemiology and treatment of cardiac inflammatory diseases (ESETCID). First epidemiological results. Herz 2000;25(3):279-85.
30. Immunoglobulin Therapy for Patients With Idiopathic Cardiomyopathy and Endomyocardial Parvovirus B19 Persistence - A Prospective, Double-blind, Randomized, Placebo-controlled Clinical Trial. https://clinicaltrials.gov/ct2/show/NCT00892112 (accessed 10 March 2015).
31. Fenoglio JJ, Ursell PC, Kellogg CF, Drusin RE, Weiss MB. Diagnosis and classification of myocarditis by endomyocardial biopsy. New England Journal of Medicine 1983;308(1):12-8.
32. Follmann D, Elliott P, Suh I, Cutler J. Variance imputation for overviews of clinical trials with continuous response. Journal of Clinical Epidemiology 1992;45(7):769-73.
33. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. Journal of the American College of Cardiology 2009;53(17):1475-87.
34. Fuse K, Kodama M, Okura Y, et al. Predictors of disease course in patients with acute myocarditis. Circulation 2000;102(23):2829-35.
35. Guglin M, Nallamshetty L. Myocarditis: diagnosis and treatment. Current Treatment Options in Cardiovascular Medicine 2012;14(6):637-51.
36. Hare JM, Baughman KL. Fulminant and acute myocarditis: the prognostic value of clinicopathological classification. European Heart Journal 2001;22(4):269-70.
37. Lefebvre C, Manheimer E, Glanville J. Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
38. Levi D, Alejos J. Diagnosis and treatment of pediatric viral myocarditis. Current Opinion in Cardiology 2001;16(2):77-83.
39. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation 2001;104(9):1076-82.
40. Maisch B, Ristic AD, Hufnagel G, Funck R, Alter P, Tontsch D, et al. Dilated cardiomyopathies as a cause of congestive heart failure. Herz 2002;27(2):113-34.
41. Maisch B, Pankuweit S. Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives. Heart Failure Reviews 2013;18(6):761-95.
42. McCarthy RE, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, et al. Long-term outcome of fulminant myocarditis as compared with acute (non-fulminant) myocarditis. New Engand Journal of Medicine 2000;342(10):690-5.
43. Meyer T, Grumbach IM, Kreuzer H, Morguet AJ. Giant cell myocarditis due to coxsackie B2 virus infection. Cardiology 1997;88(3):296-9.
44. Mounts AW, Amr S, Jamshidi R, Groves C, Dwyer D, Guarner J, et al. A cluster of fulminant myocarditis cases in children, Baltimore, Maryland, 1997. Pediatric Cardiololgy 2001;22(1):34-9.
45. Nigro G, Bastianon V, Colloridi V, Ventriglia F, Gallo P, D'Amati G, et al. Human parvovirus B19 infection in infancy associated with acute and chronic lymphocyte myocarditis and high cytokine levels: report of 3 cases and review. Clinical Infectious Diseases 2001;31(1):65-9.
46. Takeda Y, Yasuda S, Miyazaki S, Daikoku S, Nakatani S, Nonogi H. High-dose immunoglobulin G therapy for fulminant myocarditis. Japanese Circulation Journal 1998;62(11):871-2.
47. Tedeschi A, Giannini S, Ciceri L, Massari FM. High-dose intravenous immunoglobulin in the treatment of acute myocarditis. A case report and review of the literature. Journal of Internal Medicine 2002;251(2):169-73.
48. Towbin J. Myocarditis and pericarditis in adolescents. Adolescent Medicine 2001;12(1):47-67.